Amgen Inc.

Corporate group: Amgen Group

Total cases

17 (5 active)

Claimant-side

Respondent-side

Amgen Inc. has been party to 17 Unified Patent Court cases, 5 times as claimant and 12 times as respondent. The most recent on record is UPC CFI 2220/2025 at the Munich Central Division, against Sanofi-Aventis Deutschland GmbH.

Adversary analytics require an account

Recent cases

View all cases

2025-12-23UPC CFI 2220/2025Munich CD—Amgen Inc. v Sanofi-Aventis Deutschland GmbH
2025-12-23UPC CFI 2221/2025Munich CD—Amgen Inc. v Regeneron Pharmaceuticals Inc.
2025-07-14UPC CoA 641/2025Court of AppealWithdrawnSanofi Biotechnology SAS v Amgen Inc.
2025-02-28UPC CFI 195/2025Dusseldorf LDWithdrawnSanofi Biotechnology SAS v Amgen Inc.
2025-01-21UPC APP 3214/2025Munich CD—Name not displayed for GDPR reasons. Represented by Sture RYGAARD v Sanofi-Aventis Deutschland GmbH
2024-09-13UPC CoA 528/2024Court of AppealPatent upheld as grantedAmgen Inc. v Sanofi-Aventis Deutschland GmbH
2024-09-13UPC CoA 529/2024Court of AppealPatent upheld as grantedAmgen Inc. v Regeneron Pharmaceuticals Inc.
2024-08-14UPC APP 47154/2024Munich CDProcedural onlyDehns v Amgen Inc.
2024-08-14UPC APP 47163/2024Munich CDProcedural onlyDehns v Amgen Inc.
2024-08-14UPC APP 47172/2024Munich CD—Dehns v Sanofi-Aventis Deutschland GmbH